Skip to main content
Birkhäuser
Book cover

Emerging Strategies in Neuroprotection

  • Book
  • © 1992

Overview

Part of the book series: Advances in Neuroprotection (AN, volume 22)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (17 chapters)

  1. Preclinical Ischemia Model Systems

  2. Neuroprotective Approaches in Stroke and Head Trauma

  3. Clinical Endpoints for Neuroprotective Drugs

Keywords

About this book

SOLOMON H. SNYDER Receptor Research Reaches Neurology: Relevance to Neurodegenerative Diseases and Stroke President George Bush has heralded the 1990s as the decade of the brain, based largely on the rapid escalation of advances in the molecular neuro­ sciences and the likelihood that these will bear therapeutic fruit before the turn of the century. There is little doubt that the 1970s and 1980s have witnessed more remarkable advances in the molecular neurosciences than all of the preceding hundred years. Identification of receptor sites for drugs and neurotransmitters along with simple, sensitive, and specific means of monitoring them has made it possible to elucidate the mechanism of action for many known drugs and to identify new chemical entities as potential therapeutic agents. At the same time, the numbers of distinct neurotrans­ mitters have multiplied. Prior to 1970 only the biogenic amines were well accepted as transmitters. The early 1970s witnessed the gradual acceptance ofamino acids as major excitatory and inhibitory neurotransmitters. Identification of opiate receptors and the subsequent identification of the enkephalins as their endogenous ligands led to an appreciation of peptides as putative transmitters and the accumulation of as many as a hundred neuropeptides by the decade's end. In the 1980s the revolutions of molecular biology have been applied aggressively to the neurosciences with molecular cloning for neuropeptide precursors, many important neurochemical en­ zymes, and receptors for numerous transmitters.

Editors and Affiliations

  • NeuroTherapeutics Corp. and Center for Neurologic Study, San Diego, USA

    Paul J. Marangos

  • Department of Pharmacology, Texas College of Osteopathic Medicine, Fort Worth, USA

    Harbans Lal

Bibliographic Information

  • Book Title: Emerging Strategies in Neuroprotection

  • Editors: Paul J. Marangos, Harbans Lal

  • Series Title: Advances in Neuroprotection

  • DOI: https://doi.org/10.1007/978-1-4684-6796-3

  • Publisher: Birkhäuser Boston, MA

  • eBook Packages: Springer Book Archive

  • Copyright Information: Birkh�user Boston 1992

  • Softcover ISBN: 978-1-4684-6798-7Published: 29 April 2012

  • eBook ISBN: 978-1-4684-6796-3Published: 21 November 2013

  • Edition Number: 1

  • Number of Pages: XIX, 359

  • Number of Illustrations: 8 b/w illustrations

  • Topics: Science, Humanities and Social Sciences, multidisciplinary

Publish with us